Vera therapeutics reports inducement grants under nasdaq listing rule 5635(c)(4)

Brisbane, calif., dec. 09, 2024 (globe newswire) -- vera therapeutics, inc. (nasdaq: vera) today announced that on december 3, 2024, the compensation committee granted inducement awards consisting of a non-qualified stock option to purchase 171,750 shares of class a common stock and restricted stock units (rsus) for 86,625 shares of class a common stock to seventeen new employees under the inducement plan. the compensation committee approved the awards as an inducement material to the new employees' employment in accordance with nasdaq listing rule 5635(c)(4).
NDAQ Ratings Summary
NDAQ Quant Ranking